New Delhi, Apr 30 (PTI) Ajanta Pharma on Wednesday said its profit after tax increased by 11 per cent year on year to Rs 225 crore for the fourth quarter ended March 31, 2025, aided by higher sales.

The drug maker reported a profit after tax (PAT) of Rs 203 crore for the January -March quarter of last year.

Also Read | 8th Pay Commission Chairman: Who Will Head 8th CPC? Who Are the Members of the New Pay Commission? As Appointment Process Starts, Here's What We Know So Far.

Revenue from operations rose to Rs 1,170 crore in the fourth quarter as compared with Rs 1,054 crore in the year-ago period, the drug maker said in a regulatory filing.

For the entire 2024-25 fiscal, the company said its PAT rose to Rs 920 crore as against Rs 816 crore in FY24. Revenue from operations rose to Rs 4,648 crore as against Rs 4,209 crore in 2023-24.

Also Read | Who Was the Chairman of 7th Pay Commission? How Many Members Were in 7th CPC? As Govt Begins Process To Form 8th Pay Commission, Here's All You Need To Know About Previous Panel.

The company said its board re-appointed Madhusudan B. Agrawal as Executive Director and Vice Chairman of the company for a term of five years with effect from April 1, 2025.

Shares of the company on Wednesday ended 2.65 percent down at Rs 2,691.90 apiece on BSE.

(This is an unedited and auto-generated story from Syndicated News feed, LatestLY Staff may not have modified or edited the content body)